Krystal Biotech Inc reports results for the quarter ended in June - Earnings Summary

Krystal Biotech

07/08/2023 14:32

* Krystal Biotech Inc  KRYS.OQ  reported a quarterly
adjusted loss
of $1.25​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 74
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Krystal Biotech Inc's reported EPS for the quarter was a
loss of
$1.25​.
    * The mean earnings estimate of analysts had risen by
about 49.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Krystal Biotech Inc shares had risen by 5.8% this
quarter and
gained 56.8% so far this year.
    * The company reported a quarterly loss of $33.21 million.
    * Wall Street's median 12-month price target for Krystal
Biotech
Inc is $140.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.74          -1.25          Missed
 Mar. 31 2023      -1.44          -1.76          Missed
 Dec. 31 2022      -1.32          -1.25          Beat
 Sep. 30 2022      -1.22          -1.17          Beat